Trials / Sponsors / Celltex Therapeutics Corporation
Celltex Therapeutics Corporation
Industry · 5 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Corona Virus Infection, Covid19 | Phase 2 | 2024-11-01 |
| Not Yet Recruiting | Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 / Phase 2 | 2023-12-01 |
| Not Yet Recruiting | Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Osteoarthritis, Knee, Osteoarthritis, Hip, Osteoarthritis Shoulder | Phase 2 | 2023-09-25 |
| Not Yet Recruiting | Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 COVID-19 | Phase 2 | 2023-09-01 |
| No Longer Available | Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease Alzheimer Disease | — | — |